Therapeutic Potential of Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients

ACR Convergence 2023 — November 10-15, 2023 Reprinted from ACR Convergence held November 10-15, 2023. The American College of Rheumatology does not guarantee, warrant, or ...

Webinar: IgM Antibodies and Other Alternative Frameworks: Promise and Progress

Link to Webinar  April 26, 2023 Scientific innovations and advancements in antibody-based therapies, including alternative approaches using IgE, IgA, and IgM antibodies, are paving the ...

AACR 2023 Poster Presentations

AACR ANNUAL MEETING 2023 April 14 – 19, 2023 Orange County Convention Center, Orlando, Florida Apr. 17, 2023, 1:30 PM – 5:00 PM | Section ...